Alpha Tau Medical Cash Flow Statement (2020-2026) | DRTS

Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
6.95M4.81M3.81M-25.74M53.49M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.59M9.98M11.70M12.21M22.94M
Depreciation and Depletion (Quarter)
0.23M0.24M
Share-based Compensation (Quarter)
2.28M1.98M1.46M19.51M14.40M16.28M12.11M15.44M9.35M
Cash from Operations (Quarter)
-6.58M-8.74M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.23M0.24M
Change in Working Capital
Change in Account Payables (Quarter)
2.63M-2.63M
Change in Accured Expenses (Quarter)
-0.98M-0.90M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
-0.30M-0.38M
Cash from Investing Activities (Quarter)
-0.30M-92.38M
Financing Activities
Other financing activities (Quarter)
1.35M1.91M
Change in Capital Stock
Shares Issued (Quarter)
5.33M8.24M11.38M10.52M14.14M14.45M11.26M10.97M
Misc.
Cash from Financing Activities (Quarter)
81.98M14.81M
Exchange Rate Effect (Quarter)
-0.05M-0.24M
Change in Cash (Quarter)
75.05M-86.55M
Free Cash Flow (Quarter)
-6.29M-8.37M
Net Cash Flow (Quarter)
75.10M-86.31M